Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: A national cancer institute conference

Journal of Clinical Oncology

Volumn 26, Issue 5, 2008, Pages 791-797

  Buchholz, Thomas A ^a   Lehman, Constance D ^b   Harris, Jay R ^b   Pockaj, Barbara A ^b   Khouri, Nagi ^b   Hylton, Nola F ^b   Miller, Michael J ^b   Whelan, Timothy ^b   Pierce, Lori J ^b   Esserman, Laura J ^b   Newman, Lisa A ^b   Smith, Barbara L ^b   Bear, Harry D ^b   Mamounas, Eleftherios P ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; TAXANE DERIVATIVE; ANTINEOPLASTIC AGENT;

BREAST BIOPSY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PREOPERATIVE CARE; PRIORITY JOURNAL; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVIEW; SENTINEL LYMPH NODE BIOPSY; TUMOR BIOPSY; ADJUVANT THERAPY; BREAST RECONSTRUCTION; BREAST TUMOR; HEALTH CARE ORGANIZATION; ORGANIZATION; SEGMENTAL MASTECTOMY; TIME; UNITED STATES;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CONGRESSES AS TOPIC; FEMALE; HUMANS; MAMMAPLASTY; MASTECTOMY, SEGMENTAL; NATIONAL CANCER INSTITUTE (U.S.); NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; SENTINEL LYMPH NODE BIOPSY; TIME FACTORS; UNITED STATES;

EID: 39149103121     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.0326     Document Type: Review

References (44)

1. American College of Radiology (ed): ACR BIRADS: ACR Breast Imaging Reporting and Data System, Breast Imaging Atlas. Reston, VA, American College of Radiology, 2003
2. Esserman L, Hylton N, Yassa L, et al: Utility of magnetic resonance imaging in the management of breast cancer: Evidence for improved preoperative staging. J Clin Oncol 17:110-119, 1999
3. Harms SE, Flamig DP, Hesley KL, et al: MR imaging of the breast with rotating delivery of excitation off resonance: Clinical experience with pathologic correlation. Radiology 187:493-501, 1993
4. Fischer U, Kopka L, Grabbe E: Breast carcinoma: Effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213:881-888, 1999
5. Liberman L, Morris EA, Dershaw DD, et al: MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol 180:901-910, 2003
6. Mumtaz H, Hall-Craggs MA, Davidson T, et al: Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol 169:417-424, 1997
7. Schelfout K, Van Goethem M, Kersschot E, et al: Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol 30:501-507, 2004
8. Esserman L, Kaplan E, Partridge S, et al: MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol 8:549-559, 2001
9. Lehman CD, Gatsonis C, Kuhl CK, et al: MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356:1295-1303, 2007
10. Davis JT, Brill YM, Simmons S, et al: Ultrasound-guided fine-needle aspiration of clinically negative lymph nodes versus sentinel node mapping in patients at high risk for axillary metastasis. Ann Surg Oncol 13:1545-1552, 2006
11. Alvarez S, Anorbe E, Alcorta P, et al: Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: A systematic review. AJR Am J Roentgenol 186:1342-1348, 2006
12. Chagpar AB, Middleton LP, Sahin AA, et al: Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg 243:257-264, 2006
13. Balu-Maestro C, Chapellier C, Bleuse A, et al: Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Res Treat 72:145-152, 2002
14. Rosen EL, Blackwell KL, Baker JA, et al: Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 181:1275-1282, 2003
15. Weatherall PT, Evans GF, Metzger GJ, et al: MRI vs histologic measurement of breast cancer following chemotherapy: Comparison with x-ray mammography and palpation. J Magn Reson Imaging 13:868-875, 2001
16. Yeh E, Slanetz P, Kopans DB, et al: Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 184:868-877, 2005
17. Partridge SC, Gibbs JE, Lu Y, et al: Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 179:1193-1199, 2002
18. Fisher B, Brown A, Mamounas E, et al: Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowell Project B-18. J Clin Oncol 15:2483-2493, 1997
19. Kuerer HM, Newman LA, Smith TL, et al: Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 17:460-469, 1999
20. Bear HD, Anderson S, Brown A, et al: The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 21:4165-4174, 2003
21. Mamounas EP, Brown A, Anderson S, et al: Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: Results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23:2694-2702, 2005
22. Julian TB, Krag D, Brown A, et al: Preliminary technical results of NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer patients. Presented at 27th Annual San Antonio Breast Cancer Symposium, December 8-11, 2004, San Antonio, TX (abstr 14)
23. Xing YMF, Cox DD, Kuerer HM, et al: Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93:539-546, 2006
24. Shen J, Gilcrease MZ, Babiera GV, et al: Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 109:1255-1263, 2007
25. Lee S, Kim EY, Kang SH, et al: Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients. Breast Cancer Res Treat 102:283-288, 2007
26. van der Hage JA, Cornelis JH, van de Velde CJ, et al: Preoperative chemotherapy in primary operable breast cancer: Results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 19:4224-4237, 2001
27. Wolmark N, Wang J, Mamounas E, et al: Preoperative chemotherapy in patients with operable breast cancer: Nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. Cancer 96-102, 2001
28. Singletary SE, McNeese MD, Hortobagyi GN: Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma. Cancer 69:2849-2852, 1992
29. Mauri D, Pavlidis N, Ioannidis JP: Neoadjuvant versus adjuvant systemic treatment in breast cancer: A meta-analysis. J Natl Cancer Inst 97:188-194, 2005
30. Chen AM, Meric-Bernstam F, Hunt KK, et al: Breast-conserving therapy after neoadjuvant chemotherapy: The M. D. Anderson Cancer Center experience. J Clin Oncol 22:2303-2312, 2004
31. Huang EH, Strom EA, Perkins GH, et al: Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. Int J Radiat Oncol Biol Phys 66:352-357, 2006
32. Clarke M, Collins R, Darby S, et al: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366:2087-2106, 2005
33. Buchholz TA, Katz A, Strom EA, et al: Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. Int J Radiat Oncol Biol Phys 53:880-888, 2002
34. Buchholz TA, Tucker SL, Masullo L, et al: Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J Clin Oncol 20:17-23, 2002
35. Huang EH, Tucker SL, Strom EA, et al: Radiation treatment improves local-regional control and cause-specific survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol 22:4691-4699, 2004
36. McGuire SE, Gonzalez-Angulo AM, Huang EH, et al: Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 68:1004-1009, 2007
37. Mamounas T: Sentinel node biopsy after neoadjuvant chemotherapy: The pros. Presented at Preoperative Therapy in Invasive Breast Cancer: Reviewing the State of the Science and Exploring New Research Directions, March 26, 2007, National Cancer Institute, Bethesda, MD
38. Garg A, Strom EA, McNeese MD, et al: T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for local-regional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiation. Int J Radiat Oncol Biol Phys 59:138-145, 2004
39. Cordeiro PG, McCarthy CM: A single surgeon's 12-year experience with tissue expander/implant breast reconstruction: Part I, A prospective analysis of early complications. Plast Reconstr Surg 118:825-831, 2006
40. Selber JC, Kurichi JE, Vega SJ, et al: Risk factors and complications in free TRAM flap breast reconstruction. Ann Plast Surg 56:492-497, 2006
41. Behranwala KA, Dua RS, Ross GM, et al: The influence of radiotherapy on capsule formation and aesthetic outcome after immediate breast reconstruction using biodimensional anatomical expander implants. J Plast Reconstr Aesthet Surg 59:1043-1051, 2006
42. Foster RD, Hansen SL, Esserman LJ, et al: Safety of immediate transverse rectus abdominis myocutaneous breast reconstruction for patients with locally advanced disease. Arch Surg 140:196-198, 2005
43. Tran NV, Evans GR, Kroll SS, et al: Postoperative adjuvant irradiation: Effects on transverse rectus abdominis muscle flap breast reconstruction. Plast Reconstr Surg 106:313-317, 2000
44. Motwani SB, Strom EA, Schechter NR, et al: The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 66:76-82, 2006